XML 54 R29.htm IDEA: XBRL DOCUMENT
v3.25.0.1

NET INCOME PER SHARE | 12 Months Ended
--- | ---
Dec. 31, 2024
Earnings Per Share [Abstract] |
NET INCOME PER SHARE | NET INCOME PER SHARE Basic net income per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the period. Diluted net income per share is computed in a similar manner, but it also includes the effect of potential common shares outstanding during the period, when dilutive. The following table presents the computation of basic and diluted net income per share for the periods presented:
|  |  | Years Ended December 31,
|  |  |  |  | 2024 |  | 2023 |  | 2022
|  |  |  |  | (In thousands, except per share data)
Numerator: |  |  |  |  |  |  |  |  |
Net income |  |  |  |  | $ | 102,658 |  |  | $ | 438,936 |  |  | $ | 397,362 |
Convertible senior notes interest and financing costs, net of tax |  |  |  |  | 2,486 |  |  | 2,573 |  |  | 2,629 |
Adjusted net income |  |  |  |  | $ | 105,144 |  |  | $ | 441,509 |  |  | $ | 399,991 |
Denominator: |  |  |  |  |  |  |  |  |
Shares used in basic per share amounts: |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding |  |  |  |  | 135,167 |  |  | 136,376 |  |  | 135,349 |
Shares used in diluted per share amounts: |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding used for basic calculation |  |  |  |  | 135,167 |  |  | 136,376 |  |  | 135,349 |
Effect of dilutive securities: |  |  |  |  |  |  |  |  |
Employee stock-based awards |  |  |  |  | 474 |  |  | 1,782 |  |  | 3,407 |
Notes due 2023 |  |  |  |  | — |  |  | 638 |  |  | 900 |
Notes due 2025 |  |  |  |  | 288 |  |  | — |  |  | — |
2025 Warrants |  |  |  |  | — |  |  | 419 |  |  | 659 |
Notes due 2026 |  |  |  |  | 2,057 |  |  | 2,057 |  |  | 2,057 |
Notes due 2028 |  |  |  |  | 2,018 |  |  | 2,018 |  |  | 2,018 |
Weighted average common shares outstanding for diluted calculation |  |  |  |  | 140,004 |  |  | 143,290 |  |  | 144,390 |
Basic and diluted net income per share |  |  |  |  |  |  |  |  |
Net income per share, basic |  |  |  |  | $ | 0.76 |  |  | $ | 3.22 |  |  | $ | 2.94 |
Net income per share, diluted |  |  |  |  | $ | 0.75 |  |  | $ | 3.08 |  |  | $ | 2.77 |
Diluted earnings per share for the year ended December 31, 2024 includes the dilutive effect of potentially dilutive common shares by application of the treasury stock method for stock options, RSUs, PSUs, ESPP, Notes due 2025, and includes potentially dilutive common shares by application of the if-converted method for the Notes due 2026 and Notes due 2028. Potentially dilutive common shares for the year ended December 31, 2023 and 2022 include stock options, RSUs, PSUs, ESPP, Notes due 2023, Notes due 2025, Notes due 2026, Notes due 2028 and the 2025 Warrants. To the extent these potential common shares are antidilutive, they are excluded from the calculation of diluted net income per share. Further, the Company under the relevant sections of the indentures, irrevocably may elect to settle principal in cash and any excess in cash or shares of the Company’s common stock for the Notes due 2026 and Notes due 2028. If and when the Company makes such election, there will be no adjustment to the net income and the Company will use the average share price for the period to determine the potential number of shares to be issued based upon assumed conversion to be included in the diluted share count. Holders of the Notes due 2025 may now convert their notes at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of March 1, 2025. These conversions will be settled in a combination settlement method with the principal value settled in cash and the remaining value in shares of the Company’s common stock, as a result there was no adjustment to the net income for the year ended December 31, 2024, and the Company used the average share price for the period to determine the potential number of shares that will be issued and included in the diluted share count for the year ended December 31, 2024. The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net income per share attributable to common stockholders because their effect would have been antidilutive:
|  |  | Years Ended December 31,
|  |  |  |  | 2024 |  | 2023 |  | 2022
|  |  |  |  | (In thousands)
Employee stock-based awards |  |  |  |  | 1,359 |  |  | 1,113 |  |  | 135 |
Notes due 2025 |  |  |  |  | — |  |  | 1,253 |  |  | 1,253 |
2026 Warrants |  |  |  |  | 5,673 |  |  | 3,038 |  |  | 1,577 |
2028 Warrants |  |  |  |  | 5,566 |  |  | 2,981 |  |  | 1,547 |
Total |  |  |  |  | 12,598 |  |  | 8,385 |  |  | 4,512 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration